Webinar onPediatrics

Early Bird Registration End Date: Mar 07, 2025

Abstract Submission Opens: Feb 17, 2025

Coming soon...

pediatrics@globalmeetx.net

useful links

Home
About
Scientific Program
Abstract
Brochure
Regristration

Latest News

500 Bedded Pediatric Hospital Bemina: A Premier Healthcare Institution

2025-02-15 - 2025-02

SRINAGAR, FEBRUARY 15: Government Children Hospital Bemina, a 500-bedded hospital, is a premier healthcare institution catering to the population of Kashmir Division, Chenab Valley, Poonch, Rajouri and UT of Ladakh. The hospital provides comprehensive healthcare services to approximately 1200 patients daily in its Outpatient Department (OPD), with around 80-90 admissions in its Inpatient Department (IPD). Additionally, the hospital witnesses a significant footfall of around 6000 people, including patients & attendants
The hospital has highest number of critical care beds in whole UT, and critical care provided in NICU and PICU is of national and international standard.
The hospital has got fellowship programme for doctors and nurses approved in neonatology and pediatric neurology.
Further to ensure high end critical care free of cost , the government enhanced the fund allocation to the hospital and all very costly drugs like IVIG, ALBUMIN and Surfactant are available free of cost for patients.

Abstracts sought for CHRI Pediatric Research Forum

2025-02-18 - 2025-02

The Child Health Research Institute, a partnership between UNMC and Children�s Nebraska, seeks abstract submissions for the 2025 CHRI Pediatric Research Forum.
The annual research forum is an opportunity for researchers to showcase their current projects to the Child Health Research Institute community. The forum accepts all types of research with pediatric applications. Case reports/case studies and quality improvement projects will not be considered for an award but still may be featured in the forum.
Associate member: Interprofessional health care workers and research personnel from the University of Nebraska, Children�s Nebraska and Nebraska Medicine are invited to submit abstracts in the newly formed Associate Member category. The new category is reserved for researchers that do not align with preexisting categories. CHRI membership is not required but is encouraged for award consideration.

Jordan Noble’s path from patient to pediatric heart doctor

2025-02-13 - 2025-02

Three-year-old Jordan Noble told her parents she was going to be �a baby heart doctor.�
She was diagnosed with congenital heart disease as a toddler and saw a pediatric cardiologist every 6 months to a year from then on.
�As I got older, I was really interested in understanding my heart disease, understanding what was normal and what was abnormal, �she said. �I actually had the privilege of shadowing my own pediatric cardiologist when I was in high school.�
It was shortly after high school when an MRI showed her aorta was much larger than it appeared on previous echocardiograms. At 20, she underwent open heart surgery, followed by a 5-day hospital stay. A complication had her in and out of the hospital multiple times between her sophomore and junior years of college. That�s when her childhood declaration became more than a dream.
�It really became a plan after I had heart surgery and got to experience all the wonderful people that went into that and see what that looked like. I decided that I was for sure going to do medicine,� Noble said.

Opus Genetics advances gene therapy in pediatric trial

2025-02-18 - 2025-02

DURHAM, N.C. - Opus Genetics, Inc. (NASDAQ:IRD), a biotechnology firm focusing on gene therapies for inherited retinal diseases, has dosed the first pediatric patient in a Phase 1/2 clinical trial of OPGx-LCA5, an investigational treatment for Leber congenital amaurosis (LCA). According to InvestingPro data, the company maintains a strong financial position with a current ratio of 6.63, indicating robust liquidity to support its clinical programs. The company expects to release initial data from the pediatric cohort by the third quarter of 2025.

The trial, which includes adult participants, has shown early signs of success, with the first three adult patients experiencing meaningful visual improvement after treatment. These results initially observed at six months and to be further detailed with 12-month follow-up data, will be presented at a major medical conference in the second quarter of 2025. InvestingPro analysis shows that while the company is currently pre-profit, analysts have set price targets ranging from $8 to $15, suggesting significant upside potential if the trials succeed.

Contact
Terms

Webinar onPediatrics

Coming soon...

pediatrics@globalmeetx.net

support@globalmeetx.net

+44 152 836 0034

500 Bedded Pediatric Hospital Bemina: A Premier Healthcare Institution

Abstracts sought for CHRI Pediatric Research Forum

Jordan Noble’s path from patient to pediatric heart doctor

Opus Genetics advances gene therapy in pediatric trial